Inogen INGN
NASDAQ INGN
$5.61 +0.01 (+0.18%)
At close: Aug 21, 2026 · 4:00 PM EDT

Inogen (INGN) Cash from Investing Activities (2013 - 2026)

Inogen (INGN) posted quarterly Cash from Investing Activities of -$2.0 million for Q1 2026, up 3.09% year-over-year from -$1.9 million in Q1 2025, and down 30.28% quarter-over-quarter from -$1.5 million in Q4 2025.

Inogen (INGN) Cash from Investing Activities (2013 - 2026) Analysis & Trends

Inogen (INGN) has reported Cash from Investing Activities for 14 consecutive years, with -$2.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Investing Activities rose 3.09% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at -$26.1 million (down 917.75% YoY), while the FY2025 annual figure was -$26.2 million, down 87.54% from the prior year.
  • Cash from Investing Activities eased to -$2.0 million in Q1 2026 per INGN's latest filing, from -$1.5 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $11.5 million in Q4 2024 and bottomed at -$45.8 million in Q3 2023.
  • Historically, Cash from Investing Activities has averaged -$6.6 million across 5 years, with a median of -$2.0 million in 2025.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities soared 210.57% — and 2024, when it tumbled 2191.85%.
  • Inogen's Cash from Investing Activities stood at -$6.9 million in 2022, then surged by 159.45% to $4.1 million in 2023, then surged by 179.55% to $11.5 million in 2024, then tumbled by 113.14% to -$1.5 million in 2025, then sank by 30.28% to -$2.0 million in 2026.
  • Business Quant data shows INGN's Cash from Investing Activities at -$2.0 million in Q1 2026, -$1.5 million in Q4 2025, and -$82000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -673.00 Mn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -639.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -1.96 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -193.20 Mn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 329.80 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -115.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -22.08 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -108.50 Mn
10 Inogen 152.26 Mn 46.72 Mn 43.27 Mn -3.13 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.13 Mn
Jun 30, 2026 -3.13 Mn
Mar 31, 2026 -1.98 Mn
Mar 31, 2026 -1.98 Mn
Dec 31, 2025 -1.52 Mn
Dec 31, 2025 -1.52 Mn
Sep 30, 2025 -82,000.00
Sep 30, 2025 -82,000.00
Jun 30, 2025 -22.57 Mn
Jun 30, 2025 -22.57 Mn
Mar 31, 2025 -2.04 Mn
Mar 31, 2025 -2.04 Mn
Dec 31, 2024 11.54 Mn
Dec 31, 2024 11.54 Mn
Sep 30, 2024 305,000.00
Sep 30, 2024 305,000.00
Jun 30, 2024 -12.38 Mn
Jun 30, 2024 -12.38 Mn
Mar 31, 2024 -13.44 Mn
Mar 31, 2024 -13.44 Mn